Alzheimer’s Group Resources

Alzheimer’s Research Yields Potential Drug Target

Scientists at UC Santa Barbara and several other institutions have found laboratory evidence that a cluster of peptides may be the toxic agent in Alzheimer's disease. Scientists say the discovery may lead to new drugs for the disease. In an article published this week in Nature Chemistry, the researchers explain the process in which the toxic Amyloid Beta 42 peptides aggregate, and outline the new technology they use to study these peptides.

Read the original Alzheimer's Group Resources article at Alzheimer's / Dementia News From Medical News Today ...